Here is the problem: MrK has now established a history of
Here is the problem: MrK has now established a history of saying and doing stupid things, that those of us who have very large stakes in the success of this company do not appreciate or take lightly.
Caliing out the FAA.....and then asking others on the board to do the same..........is absolutely retarded. Think about it: If you are in the middle of an IRS audit, would you want someone calling the IRS and drawing undue attention to your concerns?
Well, when we all came down on him for that absurd idea, he disappeared for a while, only to now return at a very positive time in Baltia's history to make a misleading statement about Baltia THAT HAD NO LOGICAL CONCLUSION.
If he had followed through with his idea of "protecting" your investment from dilution, then his point would have been valid.
However, the way he left his point unanswered and unresolved was equivalent to many of the dawg's statements - when you read them carelessly, you get a negative image of the company.
Even the dawg has backed off recklessly and deceptively bashing Baltia as of late - and did anyone notice that he is no longer a moderator on the Hub?
LOL.......now instead of the dawg, it is "one of our own" who is carelessly and irresponsibly bashing Baltia (by "sounding" like he knows what he is talking about and misleading readers with his loose-ended logic).
If he would follow through with a logical conclusion.....instead of leading readers down a dead-end alley and misleading them with an invalid and illogical conclusion (if there even was a conclusion?), then so be it.
But instead..........we have the loose cannon back, and those of us who have a large part of our lives invested in Baltia feel the need to address that loose cannon and bring it back under wraps.
Hence..........I stick to my statement.
Jab that pen so far into his left eye that he can now write with the back of his head.
At least maybe that way his statements might have more merrit and make more sense........................
Baltia Air Lines Inc (BLTA) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
A Surprise Win in the Beauty World Who doesn't love an underdog story, right? Beverly Hills MD has slid into the limelight with their Dermal Repair Complex snagging the award for 'Beauty Product of the Year.' Talk about sending shockwaves through the beauty industry! Now, these guys might not be a household name yet, but you better believe they've got everyone's attention...
Continue Reading
Curaleaf's Bold Moves in Florida's Ganja Gold Rush Fresh out of the gate, Curaleaf is saddling up for a wild ride into Florida's cannabis frontier. They've just thrown open the doors of their latest dispensary in Riverview, cranking their statewide count up to 77. Now, isn’t that something? If you're tracking these folks, you know that bringing their nationwide total to...
Continue Reading
AI and the Music Business: A Legal Storm Brews Well, it looks like the music world’s hitting a rough patch with AI in the crosshairs. We've got Korein Tillery, a heavyweight in the legal arena, throwing down the gauntlet against Suno, an AI music-generation platform. Folks, welcome to the battleground where art meets tech and identity theft takes a whole new meaning....
Continue Reading
Rackspace's Legal Predicament: Time for Action Alright folks, if you're holding shares of Rackspace Technology (NASDAQ:RXT), it’s time to sit up and pay attention. This is about more than bad PR or a temporary hiccup in the stock price—this is serious business. We’ve got until September 28, 2026, to decide if we’re in or out on this class action lawsuit train....
Continue Reading
Eyeing a Market Surge in Clinical Trials Numbers don't lie, and they're painting a promising picture for the clinical trials services market with a solid 8% growth forecasted annually till 2031. From a modest $66.20 billion in 2026, we're looking at ballooning to a hefty $97.41 billion by 2031. What’s cooking? Let me dish it out for you. Key Drivers and Dynamics North...
Continue Reading
Redefining Aesthetic Surgery: An Artistic Approach The world of plastic surgery is often seen through the lens of beauty and symmetry, but for Dr. Emmanuel De La Cruz, it's like staring into a whole different universe. This Houston-based plastic surgeon isn't just removing fat—he's reshaping the human canvas with the eye of a sculptor. Beyond the Standard Cut and Snip...
Continue Reading
New Strategies for IVD Clinical Studies It's high time we addressed the tangled web of managing in vitro diagnostic (IVD) clinical studies. We're talking about walking a tightrope where sponsors have to juggle regulatory scrutiny, data integrity, and operational efficiency—all while pushing innovation. Simply put, the old ways of doing things just aren't cutting it...
Continue Reading
Trouble Brewin' for Capricor Investors Buckle up, folks. Capricor Therapeutics (NASDAQ: CAPR) is caught in a storm, facing not just the lengthy arm of law with a securities class action, but also a seemingly endless wait with the FDA's decision on their lead product. We're talking serious implications for anyone with skin in the game. The FDA's Delayed Blessing So the...
Continue Reading
Celebrating Two Decades of Eye Health Innovation Orbis, a name synonymous with eye care worldwide, has hit a remarkable milestone. Celebrating two decades of commitment to eye health in Macau, they've rolled out their Flying Eye Hospital with a mission of profound impact. This isn't just about a fancy airplane; it’s about real, lasting change through training projects...
Continue Reading
Ticking Clock for Wix Investors' Legal Moves The buzz in the stock market is louder than a bull on Wall Street, especially if you're tangled up with Wix.com Ltd. (NASDAQ: WIX). We've got Faruqi & Faruqi, LLP laying down serious advice: move fast or maybe lose your spot in line. The deadline to noodle over your position as a lead plaintiff in their federal securities class...
Continue Reading
Top 5 Most Recently Viewed Articles
Leadership Changes at Title Resources Group Title Resources Group (TRG), a leading title insurance underwriter, is undergoing an important executive transition. Kevin Wall is set to be appointed as the new Chief Executive Officer (CEO), succeeding J. Scott McCall, who will transition to the role of Vice Chairman of the Board of Directors. This strategic move, reflecting...
Continue Reading
Undeclared Ingredients: Not Just Another Casual Glitch Well, here we go again. Bear Stewart LLC's latest revelation sends alarm bells ringing for anyone with a nose for allergic disorders. Their Bakr Brown Butter Chocolate Chunk Ready To Bake Cookie Dough found its way to store shelves with an ingredient that can cause mayhem for many – soy. Imagine thinking you’re...
Continue Reading
The Importance of Inclusive Advertising In today's dynamic advertising landscape, inclusivity plays a critical role in how brands connect with their audiences. Inclusivity isn't just a buzzword; it's becoming essential for brands aiming to resonate with diverse demographics, reflecting the world we live in. XR Extreme Reach, a leading global technology company, has taken...
Continue Reading
Suburban Propane's Commitment to Community Well-being Suburban Propane Partners, L.P. (NYSE: SPH), a leading provider of propane and renewable energy solutions, is dedicated to making a positive impact in local communities. Recently, they partnered with Sharing House, a community organization focused on assisting those in need. This collaboration aimed to gather essential...
Continue Reading
GoHealth's Significant Stock Surge Recently, GoHealth Inc. (GOCO) has made headlines as it reached a remarkable milestone by hitting a 52-week high of $14.94. This achievement illustrates a substantial 12% gain over the past week and a phenomenal 40% surge over the last six months. Investors and market analysts have been captivated by these developments, considering the...
Continue Reading
